Status:
NOT_YET_RECRUITING
Continuous Renal Replacement Therapy Doses in Critically Ill Patients With Acute Kidney Injury
Lead Sponsor:
Fundacion Clinic per a la Recerca Biomédica
Collaborating Sponsors:
Hospital Clinic i provincial de Barcelona
Conditions:
Renal Replacement Therapy for Acute Kidney Injury in ICU
Continuous Renal Replacement Therapy (CRRT)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Acute kidney injury in critically ill patients admitted to the ICU is a common complication associated with high mortality or long-term chronic kidney damage. Some of these patients require continuous...
Eligibility Criteria
Inclusion
- Patients 18 years of age or older
- Acute renal failure (AKIN 3) requiring Continuous Renal Replacement Therapy
- Requirement of vasoactive drugs (norepinephrine \> 0.1 mcg/kg/min)
- Written informed consent (patient or family)
Exclusion
- Lack of informed consent.
- Possibility of using plasma exchange or MARS therapy at the at the time of inclusion.
- Baseline renal function with an estimated glomerular filtration rate (CKD-EPI) less than 30 ml/min.
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06901011
Start Date
August 1 2025
End Date
August 1 2027
Last Update
July 17 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.